Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VECTUS BIOSYSTEMS LIMITED Capital/Financing Update 2022

Nov 20, 2022

65993_rns_2022-11-20_c69833c8-2917-4597-bfa0-567d95452087.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Market Announcement

==> picture [33 x 50] intentionally omitted <==

21 November 2022

==> picture [451 x 5] intentionally omitted <==

Vectus Biosystems Limited (ASX: VBS) – Trading Halt

Description

The securities of Vectus Biosystems Limited (‘VBS’) will be placed in trading halt at the request of VBS, pending it releasing an announcement concerning the finalisation of a material fundraising. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 23 November 2022 or when the announcement is released to the market.

Issued by

Lisa Banh

Senior Adviser, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

21 November 2022 ASX Limited

==> picture [513 x 94] intentionally omitted <==

21 November 2022

Ms L Banh Senior Advisor Listings Compliance (Sydney) ASX Compliance Pty Limited 20 Bridge Street, Sydney NSW 2000

Dear Lisa

Request for Trading Halt - Vectus Biosystems Limited (ASX Code:VBS)

Vectus Biosystems Limited (the Company) (ASX:VBS) requests a trading halt to be applied to its securities under ASX Listing Rule 17.1 pending an announcement to the market concerning the finalisation of a material fundraising.

The Company would like the trading halt to commence immediately for a period of up to two days.

The Company expects to make an announcement concerning the fundraising before trading commences on Wednesday, 23 November 2022.

The Company is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt.

Yours sincerely

Vectus Biosystems Limited

==> picture [91 x 51] intentionally omitted <==

Robert J Waring Company Secretary

Vectus Biosystems Limited

ABN 54 117 526 137

Corporate Division: 3-11 Primrose Avenue, Rosebery NSW 2018 Tel: 61 2 9662 4144 Fax: 61 2 9662 6040

Research Division: Level 3, CSIRO Building, 11 Julius Avenue, North Ryde NSW 2112 Tel: 61 2 8876 8200 Fax: 61 2 9870 7420